Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale.
Int J Gynecol Cancer
; 26(9): 1690-1693, 2016 11.
Article
em En
| MEDLINE
| ID: mdl-27779548
ABSTRACT
Eighty-seven percent of cervix cancer occurs in less-developed regions of the world, and there is up to an 18-fold difference in mortality rate for cervix cancer depending on the region of the world. The Cervix Cancer Research Network (CCRN) was founded through the Gynecologic Cancer InterGroup with the aim of improving access to clinical trials in cervix cancer worldwide, and in so doing improving standards of care. The CCRN recently held its first international educational symposium in Bangkok. Sixty-two participants attended from 16 different countries including Pakistan, India, Bangladesh, Thailand, Malaysia, Singapore, Philippines, Taiwan, China, Vietnam, Korea, Japan, Columbia, Brazil, Canada, and the United States. The focus of this symposium was to evaluate progress, to promote new clinical trials for the CCRN, and to provide education regarding the role of brachytherapy in the treatment of cervical cancer.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias do Colo do Útero
/
Ensaios Clínicos como Assunto
/
Países em Desenvolvimento
Tipo de estudo:
Guideline
Aspecto:
Determinantes_sociais_saude
Limite:
Female
/
Humans
Idioma:
En
Revista:
Int J Gynecol Cancer
Ano de publicação:
2016
Tipo de documento:
Article